Study of a new drug for advanced solid tumors with her2
Treatments studied
Part of Cancer clinical trials.
This trial tests an investigational drug (SHR-4602) alone or with other treatments for advanced solid tumors that have HER2. The goal is to see if it can shrink or control the cancer.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 80 years old.
- You are able to do daily activities on your own (like walking and doing light chores).
- Your cancer is advanced (spread or cannot be removed with surgery) and you have already had at least one round of standard treatment that didn't work.
- A biopsy or old tissue sample shows your tumor has HER2 (a protein that some cancers make).
- You have a tumor that can be measured on a scan, and your doctor expects you to live at least 12 more weeks.
- You do not have uncontrolled brain metastases, active autoimmune diseases, or certain lung or heart conditions.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial is testing a new drug, SHR-A2102, either alone or with other treatments, for people with advanced solid tumors that have stopped responding to standard therapy. The goal is to see if it can shrink tumors or slow the cancer's growth.
This trial tests a new drug called SHR-1826 for people with advanced solid tumors that have not responded to or are no longer helped by standard treatments. It is an early-phase study (Phase 1) to see if the drug is safe and how well it works.
This trial tests a new drug called SHR-3821 for people with advanced solid tumors that have not responded to standard treatments. The goal is to see if it is safe and effective.
This trial tests a new drug, SHR-1826, combined with other cancer treatments for people with advanced solid tumors that have not responded to prior therapy. The goal is to see if the combination is safe and effective.
This study tests an investigational drug called SHR-9803 in people with advanced solid tumors that have not responded to standard treatments. The goal is to see if it is safe and effective in shrinking or slowing the growth of tumors.
This trial tests a new drug called SHR-3792 for people with advanced solid tumors that cannot be removed by surgery or have spread. The goal is to see if the drug is safe and how it affects the tumors.
Hear when a new Advanced Solid Tumors trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.